SCHEMBL1745229

SCHEMBL1745229

Cc1nc(OCC2(F)CCOCC2)sc1[S+]([O-])NC(=O)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cccc2[nH]cnc12

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 4/20 0.81
▸ BCL2L1 Q07817 4/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1744369 0.89 BCL2 (1.00) BCL2BCL2L1
SCHEMBL1956747 0.84 BCL2 (0.80) BCL2BCL2L1
SCHEMBL1956281 0.83 BCL2 (0.77) BCL2BCL2L1
SCHEMBL1957709 0.82 BCL2 (0.79) BCL2BCL2L1
SCHEMBL1955710 0.82 BCL2 (0.60) BCL2BCL2L1
SCHEMBL1957833 0.82 BCL2 (0.78) BCL2BCL2L1
SCHEMBL1955935 0.81 BCL2 (0.63) BCL2
SCHEMBL1743443 0.81 BCL2 (1.00) BCL2BCL2L1
SCHEMBL1957158 0.80 BCL2 (0.78) BCL2
SCHEMBL18240011 0.78 BCL2 (0.79) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387559-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-11-23 — — EP claimed
WO-2010083442-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-07-22 — — WO claimed
Send feedback